Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chen, Kehe
NCT03941574: A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy	Recruiting	2	108	RoW	HLX10	Shanghai Henlius Biotech	MSI-H Solid Malignant Tumor	05/24	06/26
TranStar102, NCT04495296: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors	Recruiting	1/2	320	RoW	TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Nivolumab	Suzhou Transcenta Therapeutics Co., Ltd., Bristol-Myers Squibb	Advanced Cancer	02/25	05/25
AFHC, NCT04954521: Anlotinib for Hepatocellular Carcinoma	Recruiting	N/A	200	RoW	Anlotinib	Guangxi Zhuang Autonomous Region People's Hospital	Liver Neoplasms	07/23	07/24
Chen, Luwen
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).	Not yet recruiting	N/A	1000	RoW	Continuous Glucose Monitoring System (GX-01S)	Nanjing First Hospital, Nanjing Medical University	Type1 Diabetes Mellitus	10/26	06/27